DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2003

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended

30/09/2003
Quarter3
Financial Year End31/12/2003
The figureshave not been audited

Attachments

DBIOTEC-Q3 2003-20031108.xls
90 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2003


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2003 
30/09/2002 
30/09/2003 
30/09/2002 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
18,057
15,828
57,839
27,660
2Profit/(loss) before tax
5,839
4,871
17,931
8,035
3Profit/(loss)
after tax and minority
interest
4,325
3,522
13,242
5,910
4Net profit/(loss) for
the period
4,325
3,522
13,242
5,910
5Basic earnings/(loss) per share (sen)
8.65
7.13
26.48
24.37
6Dividend per share (sen)
0.00
0.00
5.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

1.6600
1.5000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The results of the Group for the preceding year corresponding period ended 30 September 2002 is consolidated from the date of acquisition of Duopharma (M) Sendirian Berhad ("DMSB"). Accordingly, the Group's income statement for the preceding year corresponding period ended 30 September 2002 would only reflect the 5 months apportionment results of DMSB.

The proforma nine (9) months results of the Group for period ended 30 September 2002 is reflected in note B1 to the interim financial statements.


Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced20 Nov 2003  
CategoryFinancial Results
Reference NoCS-031118-32535